Tag: #Global Trends

The biopharma workforce reductions continue into the new year as a neurology-focused biotech announces its closure following clinical disappointment. The... Read more

The exit of the neuroscience director leaves half of the NIH’s institutes under interim management, raising concerns over institutional stability.... Read more

The GI-focused biotech firm targets significant revenue growth driven by its leading therapy and advanced clinical pipeline. Ironwood Pharmaceuticals has... Read more

Regulators demand further evidence of relacorilant’s clinical efficacy before granting market authorization. As 2025 drew to a close, the U.S.... Read more

The Supreme Court's ruling in Beijing bolsters the Danish pharmaceutical firm's position against rivals and generic alternatives. In a landmark... Read more

The French biotech firm has ended its cooperation with the world’s largest vaccine manufacturer to gain direct oversight of its... Read more

On the first day of 2026, the biotechnology firm Enveric Biosciences announced the issuance of a new US patent for... Read more

In late 2025, the pharmaceutical landscape saw a strategic shift as Emmaus Life Sciences officially transferred the commercial rights of... Read more

Strategic price cuts to bolster market dominance The Danish pharmaceutical giant Novo Nordisk has significantly reduced the price of its... Read more